Actionable insights that drive discovery
Metabolon’s Precision Metabolomics™ LC-MS global metabolomics platform provides a high-fidelity, reproducible analysis of the current-state of a biological system to help identify pharmacodynamic, efficacy and response biomarkers and reveal changes in key biological pathways. Metabolon’s unmatched chemical library and expertise identifies, tracks, and maps the different classes of metabolites and pathways that inform your study and reveal meaningful actionable insights.
If the genome can be considered the most foundational of systems biology approaches in drug discovery and personalized medicine, the metabolome can be considered the most functional. If your molecule has a specific effect in an organism, metabolites leave the clearest fingerprint of those effects.
The key to unlocking any biological system is to consider every factor impacting the phenotype – genetics, diet, environment, disease, drug exposure, and the microbiome all exert their influences by altering metabolite levels.
Incomplete metabolomic coverage creates a fragmented and anecdotal view that leads to uncertainty and misleading conclusions. Metabolon’s industry leading coverage and quality accurately identifies over 5,200 metabolites, providing the most comprehensive mechanistic view of the underlying biology for complete, accurate, and confident interpretation that delivers knowledge, not just data.
Metabolomics integrates many other sources of biological variability (clinical measurements, genomics, etc.), to provide deep insight. As the definitive representative of a phenotype, it is the final piece of multi-omics solution, helping to triangulate upstream gene expression and downstream function of metabolites and lipids to substantiate the identities of molecular entities and provide greater confidence in the importance of a particular biochemical pathway.